In the News

LACRIFILL^® Canalicular Gel is changing clinical practice and changing lives when it comes to dry eye treatment.

Latest News

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces the Launch of LACRIFILL^® Canalicular Gel, a Novel Therapy for Dry Eye

05/29/24

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), to Present Data on LACRIFILL^® Canalicular Gel, a Novel Therapy for Dry Eye, at the American Society of Cataract and Refractive Surgery Annual Meeting

04/02/24

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board

03/14/24

Amring Pharmaceuticals Inc. announces name change to Nordic Pharma, Inc. under new Nordic Group, B.V. ownership

03/04/24

« Older Entries



Upcoming Tradeshows

AAO 2024
October 18-21, 2024 | Chicago, IL